ZNF320 is a hypomethylated prognostic biomarker involved in immune infiltration of hepatocellular carcinoma and associated with cell cycle
Figure 2.ZNF320 expression is a correlation with clinicopathological characteristics. Increased ZNF320 expression was significantly with (A) higher grade, (B) stage, (C) nodal metastasis, (D) gender, (E) age, and (F) weight.